ATI-1 mediated disruption of the VCP–UFL1–Beclin1 axis thwarts autophagy initiation to trigger metabolic catastrophe in autophagy-addicted cancers
- 25 April 2026
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 177, 109923
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Sichuan Province (2025ZNSFSC0691)
This publication has 45 references indexed in Scilit:
- Structural insights into Beclin 1 interactions with it's regulators for autophagy modulationComputational and Structural Biotechnology Journal, 2025
- Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapyActa Pharmaceutica Sinica B, 2023
- Recent advances in targeting autophagy in cancerTrends in Pharmacological Sciences, 2023
- Autophagy is a major metabolic regulator involved in cancer therapy resistanceCell Reports, 2021
- Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug DiscoveryJournal of Chemical Information and Modeling, 2020
- Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replicationChromosoma, 2016
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SBJournal of Chemical Theory and Computation, 2015
- Should I stay or should I go: VCP/p97-mediated chromatin extraction in the DNA damage responseExperimental Cell Research, 2014
- Autophagosome formation—The role of ULK1 and Beclin1–PI3KC3 complexes in setting the stageSeminars in Cancer Biology, 2013
- Development and testing of a general amber force fieldJournal of Computational Chemistry, 2004